Pharvaris officer plans $1.0M, 26K-share sale

An officer of Pharvaris N.V. filed a Rule 144 notice to potentially sell 26,090 PHVS common shares, including vested restricted stock and option shares.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) has an officer, Wim Souverijns, filing a notice of proposed sale of company common shares under Rule 144. The filing covers up to 26,090 shares of Pharvaris common stock to be sold through Morgan Stanley Smith Barney LLC, with a stated aggregate market value of $1,023,583.19 as of September 14, 2026 on NASDAQ. The shares consist of 6,090 restricted stock acquired from the issuer upon vesting between March 12 and August 12, 2026 and 20,000 shares issuable from a stock option exercise dated September 14, 2026.

Key Figures

Shares covered by Rule 144 notice: 26,090 shares Aggregate market value: $1,023,583.19 Restricted stock component: 6,090 shares +3 more

6 metrics

Shares covered by Rule 144 notice 26,090 shares Common stock to be sold through Morgan Stanley Smith Barney LLC

Aggregate market value $1,023,583.19 Value of 26,090 Pharvaris common shares as of September 14, 2026

Restricted stock component 6,090 shares Restricted stock acquired from issuer, related to the proposed sale

Stock option exercise component 20,000 shares Shares from a stock option exercise dated September 14, 2026

Notice date September 14, 2026 Date of Form 144 notice signed by Wim Souverijns

Restricted stock vesting period March 12, 2026 to August 12, 2026 Period during which the restricted stock vested

Key Terms

Rule 144, Restricted Stock, Stock Option Exercise, Executive Financial Services

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 03/12/2026 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Stock Option Exercise financial

"Common | 09/14/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Pharvaris N.V. (PHVS)?

It discloses that officer Wim Souverijns has filed a notice of intent under Rule 144 to potentially sell up to 26,090 shares of Pharvaris common stock through Morgan Stanley Smith Barney LLC on NASDAQ.

How many PHVS shares are covered by this Rule 144 notice?

The notice covers up to 26,090 Pharvaris common shares, with a stated aggregate market value of $1,023,583.19 as of September 14, 2026.

What types of Pharvaris (PHVS) securities are included in the 26,090 shares?

The 26,090 shares include 6,090 shares of restricted stock acquired from the issuer and 20,000 shares related to a stock option exercise, both in Pharvaris common stock.

When were the Pharvaris (PHVS) restricted shares acquired?

The filing states that the restricted stock underlying the sale was acquired upon vesting during the period from March 12, 2026 through August 12, 2026.

Who is the broker for the proposed sale of PHVS shares under this Form 144?

The proposed sale of Pharvaris common stock is to be effected through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY.

On which market are the Pharvaris (PHVS) shares referenced in this filing traded?

The filing lists the Pharvaris common shares for this Rule 144 notice as traded on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 06:26 PM Accepted by SEC EDGAR 09/14/2026 - 06:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973529
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	WIM SOUVERIJNS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	26090	1023583.19	70204506	09/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/12/2026	Restricted Stock	Issuer			6090	03/12/2026	Not Applicable
Common	09/14/2026	Stock Option Exercise	Issuer			20000	09/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock during the period of 3/12/2026 through 8/12/2026.
Date of Notice	09/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Wim Souverijns
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)